Acute Coronary Syndromes Clinical Trials

28 recruiting

Acute Coronary Syndromes Trials at a Glance

23 actively recruiting trials for acute coronary syndromes are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Baia Mare, Baltimore, and Barcelona. Lead sponsors running acute coronary syndromes studies include Acibadem University, Aristotle University Of Thessaloniki, and Abcentra.

Browse acute coronary syndromes trials by phase

Treatments under study

About Acute Coronary Syndromes Clinical Trials

Looking for clinical trials for Acute Coronary Syndromes? There are currently 28 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Coronary Syndromes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Coronary Syndromes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Not Applicable

Point-of-Care Troponin Testing in the Emergency Department

Acute Coronary Syndromes
KU Leuven1,552 enrolled1 locationNCT06845826
Recruiting

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Endothelial Function (FMD)Acute Coronary SyndromesFlow Mediated Dilation
Aristotle University Of Thessaloniki100 enrolled1 locationNCT06890013
Recruiting
Early Phase 1

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients

Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes
Cyclarity Therapeutics, Inc.84 enrolled1 locationNCT06813339
Recruiting
Phase 2

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Not Applicable

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

DyspneaAcute Coronary SyndromesTicagrelor
Acibadem University110 enrolled2 locationsNCT07268859
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Myocardial IschemiaCoronary Artery DiseaseIschemic Heart Disease+3 more
Biotronik AG100 enrolled8 locationsNCT07091682
Recruiting
Not Applicable

Oregano and Basil Leaves and Coronary Artery Disease

Acute Coronary SyndromesUnstable Angina (UA)
Shahid Beheshti University of Medical Sciences70 enrolled1 locationNCT07123181
Recruiting
Not Applicable

Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)

Acute Coronary SyndromesHome Based Rehabilitation
Gadjah Mada University90 enrolled2 locationsNCT06625463
Recruiting

Mechanisms And Prognosis of Stroke-Heart Syndrome

Heart FailureStrokeMyocardial Injury+5 more
Chensheng Pan658 enrolled1 locationNCT06954103
Recruiting

Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

Acute Coronary Syndromes
Yun Dai Chen6,000 enrolled1 locationNCT06738758
Recruiting
Phase 4

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

Acute Coronary Syndromes
King Edward Medical University152 enrolled1 locationNCT06765265
Recruiting

PRemature Acute Myocardial Infarction Register of Serbia

Acute Coronary Syndromes
Cardiology Society of Serbia1,000 enrolled11 locationsNCT06753591
Recruiting

Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study

Acute Coronary Syndromes
Cambridge University Hospitals NHS Foundation Trust60 enrolled1 locationNCT06427694
Recruiting

Prospective Registry of Acute Coronary Syndromes in Ferrara

Acute Coronary Syndromes
University Hospital of Ferrara10,000 enrolled1 locationNCT02438085
Recruiting

Exploring the Utility of Non-Invasive Coronary Angiography in Suspected Acute Coronary Syndromes with Low Level Troponin Elevation. (EN-ACT): A national study

Acute Coronary Syndromes
Flinders University3,000 enrolled5 locationsACTRN12622001316796
Recruiting

Effect of a 8 and 12-week exercise program on aerobic capacity after percutaneous revascularization in subjects with Acute Coronary Syndromes

Acute Coronary Syndromes
Juan Carlos Sánchez Delgado40 enrolled1 locationACTRN12620000363987
Recruiting
Phase 4

Biomarker-guided Management Following a Heart Attack

Secondary prevention post-acute coronary syndromesCardiovascular Disease
Professor Rob Doughty1,028 enrolled1 locationACTRN12619001445167
Recruiting

The Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events

Acute Coronary Syndromes
Sydney Local Health District8,000 enrolled43 locationsACTRN12614000887673
Recruiting

The Australian Grace Risk score Intervention study (AGRIS): a hospital level cluster randomised clinical trial with blinded endpoint evaluation which aims to enhance evidence based decision making and outcome delivery of Australian Acute Coronary Syndrome (ACS) care by evaluating a GRACE Risk score based decision support tool versus standard care

Acute Coronary Syndromes
Sydney Local Health District - Concord Hospital1,900 enrolled22 locationsACTRN12614000550606
Recruiting

The Central Australian Heart Protection Study: A Randomised Trial of Nurse-Led, Family Based Secondary Prevention of Acute Coronary Syndromes.

Acute Coronary Syndromes
Baker IDI Heart and Diabetes Institute360 enrolled1 locationACTRN12614000284662